Disulfide-Mediated Oligomer Formation in Borrelia burgdorferi Outer Surface Protein C, a Critical Virulence Factor and Potential Lyme Disease Vaccine Candidate

被引:12
作者
Earnhart, Christopher G. [1 ]
Rhodes, DeLacy V. L. [1 ]
Marconi, Richard T. [1 ,2 ]
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Dept Microbiol & Immunol, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Med Coll Virginia, Ctr Study Biol Complex, Richmond, VA 23298 USA
关键词
IXODES-SCAPULARIS; CRYSTAL-STRUCTURE; MAMMALIAN HOST; SENSU-STRICTO; OSPC GENE; ANTIBODY-RESPONSE; CIRCULAR PLASMID; IMMUNE-RESPONSE; SALIVARY-GLANDS; CELL ACTIVATION;
D O I
10.1128/CVI.05004-11
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Borrelia burgdorferi OspC is an outer membrane lipoprotein required for the establishment of infection in mammals. Due to its universal distribution among B. burgdorferi sensu lato strains and high antigenicity, it is being explored for the development of a next-generation Lyme disease vaccine. An understanding of the surface presentation of OspC will facilitate efforts to maximize its potential as a vaccine candidate. OspC forms homodimers at the cell surface, and it has been hypothesized that it may also form oligomeric arrays. Here, we employ site-directed mutagenesis to test the hypothesis that interdimeric disulfide bonds at cysteine 130 (C130) mediate oligomerization. B. burgdorferi B31 ospC was replaced with a C130A substitution mutant to yield strain B31::ospC(C130A). Recombinant protein was also generated. Disulfide-bond-dependent oligomer formation was demonstrated and determined to be dependent on C130. Oligomerization was not required for in vivo function, as B31::ospC(C130A) retained infectivity and disseminated normally. The total IgG response and the induced isotype pattern were similar between mice infected with untransformed B31 and those infected with the B31::ospC(C130A) strain. These data indicate that the immune response to OspC is not significantly altered by formation of OspC oligomers, a finding that has significant implications in Lyme disease vaccine design.
引用
收藏
页码:901 / 906
页数:6
相关论文
共 52 条
[1]   Salp15, an Ixodes scapularis salivary protein, inhibits CD4+ T cell activation [J].
Anguita, J ;
Ramamoorthi, N ;
Hovius, JWR ;
Das, S ;
Thomas, V ;
Persinski, R ;
Conze, D ;
Askenase, PW ;
Rincón, M ;
Kantor, FS ;
Fikrig, E .
IMMUNITY, 2002, 16 (06) :849-859
[2]  
BARBOUR AG, 1984, YALE J BIOL MED, V57, P521
[3]   SPIROCHETES ISOLATED FROM THE BLOOD OF 2 PATIENTS WITH LYME-DISEASE [J].
BENACH, JL ;
BOSLER, EM ;
HANRAHAN, JP ;
COLEMAN, JL ;
HABICHT, GS ;
BAST, TF ;
CAMERON, DJ ;
ZIEGLER, JL ;
BARBOUR, AG ;
BURGDORFER, W ;
EDELMAN, R ;
KASLOW, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (13) :740-742
[4]   ospC diversity in Borrelia burgdorferi:: Different hosts are different niches [J].
Brisson, D ;
Dykhuizen, DE .
GENETICS, 2004, 168 (02) :713-722
[5]   Conspicuous impacts of inconspicuous hosts on the Lyme disease epidemic [J].
Brisson, Dustin ;
Dykhuizen, Daniel E. ;
Ostfeld, Richard S. .
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2008, 275 (1631) :227-235
[6]   Global analysis of Borrelia burgdorferi genes regulated by mammalian host-specific signals [J].
Brooks, CS ;
Hefty, PS ;
Jolliff, SE ;
Akins, DR .
INFECTION AND IMMUNITY, 2003, 71 (06) :3371-3383
[7]   Analysis of antibody response in humans to the type A OspC loop 5 domain and assessment of the potential utility of the loop 5 epitope in Lyme disease vaccine development [J].
Buckles, Eric L. ;
Earnhart, Christopher G. ;
Marconi, Richard T. .
CLINICAL AND VACCINE IMMUNOLOGY, 2006, 13 (10) :1162-1165
[8]   Access of antibody or trypsin to an integral outer membrane protein (P66) of Borrelia burgdorferi is hindered by Osp lipoproteins [J].
Bunikis, J ;
Barbour, AG .
INFECTION AND IMMUNITY, 1999, 67 (06) :2874-2883
[9]   LYME-DISEASE - A TICK-BORNE SPIROCHETOSIS [J].
BURGDORFER, W ;
BARBOUR, AG ;
HAYES, SF ;
BENACH, JL ;
GRUNWALDT, E ;
DAVIS, JP .
SCIENCE, 1982, 216 (4552) :1317-1319
[10]   Salp25D, an Ixodes scapularis antioxidant, is 1 of 14 immunodominant antigens in engorged tick salivary glands [J].
Das, S ;
Banerjee, G ;
DePonte, K ;
Marcantonio, N ;
Kantor, FS ;
Fikrig, E .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (08) :1056-1064